what activates glp 1 receptors Physiological roles of different GLP‐1 receptor (GLP‐1R) signalling Glucagon Like Peptide 1 Receptor

The Ozempic label notes that about 0.2 percent of patients reported injection site reactions in placebo-controlled trials

McKesson gets the higher weightage as GLP1 scripts already account for roughly oneeighth of its revenue and are the single biggest contributor to its recent profit upgrades

This central effect is a key reason why GLP-1 agonists are so effective for weight loss

Long-acting medications like semaglutide and tirzepatide tend to report higher rates of both diarrhea and constipation compared to short-acting options like exenatide

Pharma is innovating to hit even more targets The latest article I saw about the work being done in this class is a study in mice looking at a quintuple agonist (5 different targets!) I almost never write about mice studies because of how preliminary they are and how unlikely a finding in mice is to ever translate into anything useful in humans, but because of the success weve already seen of this drug class as well as the way that hitting more pathways seems to increase efficacy, I thought this was research worth highlighting

PMID: 16410542